To analyze if AKT3 plays a role in neuroendocrine differentiation of prostate carcinoma, we validated AKT3 expression in NE-like LNCaP cells compared to undifferentiated LNCaP cells in four independent differentiations by qRT-PCR (Figure 1A). Here, AKT3 is linked to prostate carcinoma.